Should urine polymerase chain reaction for Neisseria gonorrhoeae and Chlamydia trachomatis be used as a screening test in women?

Date First Published:
October 13, 2005
Last Updated:
October 17, 2005
Report by:
Fred C Ko, Resident (George Washington University)
Three-Part Question:
In [women] is [N. gonorrhoeae and C. trachomatis PCR on urine samples more sensitive than that of cervical samples] in [detecting gonococcal and chlamydial infection]?
Clinical Scenario:
An asymptomatic 25 year old female requesting for a screening gonorrhea and chlamydia test at a primary care clinic. The patient is actively menstruating and a speculum exam cannot be performed at the time of evaluation.
Search Strategy:
Pubmed 1990-2005
Search Details:
Limit to English Language and Human
(gonorrhea[Text Word] OR gonorrhoea[Text Word] OR "gonorrhea"[MeSH Terms]) AND ("chlamydia"[MeSH Terms] OR ("chlamydia infections"[TIAB] NOT Medline[SB]) OR "chlamydia infections"[MeSH Terms] OR chlamydia[Text Word]) AND ("nucleic acids"[TIAB] NOT Medline[SB]) OR "nucleic acids"[MeSH Terms] OR nucleic acid[Text Word]) AND amplification[All Fields])
Outcome:
52 articles were identified. Only one study was a meta-analysis that assessed the sensitivity and specificity of nucleic acid amplification tests for C. trachomatis and N. gonorrhoeae of urine and cervical samples in women.
Relevant Paper(s):
Study Title Patient Group Study type (level of evidence) Outcomes Key results Study Weaknesses
Systematic Review: Noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB Jun-05 USA C. trachomatis:
14 studies
n = 11,327
Meta-analysis Urine sample PCR Sensitivity 83.3% (95% CI, 77.7% to 88.9%)
Cervical sample PCR Sensitivity 85.5% (95% CI, 80.3% to 90.6%)
Bottom Line:
Urine PCR for N. gonorrhoeae in women has a much lower sensitivity than traditional cervical sampling. Urine PCR should not be used for routine gonorrhea screening if the patient is agreeable to a speculum exam.
Urine PCR for C. trachomatis in women is equal in sensitivity to that of cervical samples and is an adequate screening tool for chlamydia.
References:
  1. Cook RL, Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic Review: Noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae